Cargando…

Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia

Asparaginase is an integral component of acute lymphoblastic leukemia (ALL)() treatment. Hepatotoxicity related to asparaginase is one of the most common treatment-related toxicities in ALL therapy. Hispanic children are at higher risk of developing ALL, and toxicities from ALL therapy. The rs4880 v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Sharon, Wang, Mengxi, Alqahtani, Amani, Lou, Mimi, Stock, Wendy, Bhojwani, Deepa, Alachkar, Houda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450009/ https://www.ncbi.nlm.nih.gov/pubmed/35658244 http://dx.doi.org/10.1016/j.biopha.2022.113000

Ejemplares similares

Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia
por: Alachkar, Houda, et al.
Publicado: (2016)

Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
por: Siokas, Vasileios, et al.
Publicado: (2022)

SOD2 Gene Variants (rs4880 and rs5746136) and Their Association with Breast Cancer Risk
por: Gallegos-Arreola, Martha P., et al.
Publicado: (2022)

Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia
por: Alqahtani, Amani, et al.
Publicado: (2023)

Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness
por: Nikic, Predrag, et al.
Publicado: (2023)

Association of SOD2 (rs4880) and GPX1 (rs1050450) Gene Polymorphisms with Risk of Balkan Endemic Nephropathy and its Related Tumors
por: Dragicevic, Biljana, et al.
Publicado: (2019)

Link between MnSOD Ala16Val (rs4880) polymorphism and asthma risk is insignificant from sequential meta-analysis
por: Alhobeira, Hazza A, et al.
Publicado: (2020)

Association of NOS3 (rs 2070744) and SOD2Val16Ala (rs4880) gene polymorphisms with increased risk of ESRD among Egyptian patients
por: Elsaid, Afaf, et al.
Publicado: (2021)

SOD2 rs4880 and GPX1 rs1050450 polymorphisms do not confer risk of COVID-19, but influence inflammation or coagulation parameters in Serbian cohort
por: Jerotic, Djurdja, et al.
Publicado: (2022)

The Association of Polymorphisms in Genes Encoding Antioxidant Enzymes GPX1 (rs1050450), SOD2 (rs4880) and Transcriptional Factor Nrf2 (rs6721961) with the Risk and Development of Prostate Cancer
por: Djokic, Milica, et al.
Publicado: (2022)

CDKN2B‐AS (rs2891168), SOD2 (rs4880), and PON1 (rs662) polymorphisms and susceptibility to coronary artery disease and type 2 diabetes mellitus in Iranian patients: A case‐control study
por: Yari, Abolfazl, et al.
Publicado: (2023)

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

Proteomics Study on Nonallergic Hypersensitivity Induced by Compound 4880 and Ovalbumin
por: Xu, Yubin, et al.
Publicado: (2016)

2193: Targeting MELK in acute lymphoblastic leukemia, new therapeutic approach
por: Alachkar, Houda, et al.
Publicado: (2018)

L-Asparaginase induced thrombosis in acute lymphoblastic leukemia
por: Kulkarni, Ketan P.
Publicado: (2012)

Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
por: Hijiya, Nobuko, et al.
Publicado: (2016)

L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
por: Egler, Rachel A., et al.
Publicado: (2016)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
por: M'harzi, Soulaimane, et al.
Publicado: (2022)

Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases
por: Müller, Judit, et al.
Publicado: (2023)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020)

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
por: Vrooman, Lynda M., et al.
Publicado: (2015)

Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia
por: Avramis, Vassilios I, et al.
Publicado: (2006)

L-asparaginase-induced Parotitis in an Elderly Patient with Acute Lymphoblastic Leukemia
por: Saburi, Masuho, et al.
Publicado: (2020)

L-Asparaginase Toxicity in the Treatment of Children and Adolescents with Acute Lymphoblastic Leukemia
por: Schmidt, Madalina-Petronela, et al.
Publicado: (2021)

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
por: Chenbah, Wafa, et al.
Publicado: (2023)

Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)()
por: Mutonga, Martin, et al.
Publicado: (2015)

Efficacy and safety of PEG-asparaginase versus E. coli L-asparaginase in Chinese children with acute lymphoblastic leukemia: a meta-analysis
por: Dai, Zhan-Jing, et al.
Publicado: (2021)

A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition
por: Tan, Yan Qi, et al.
Publicado: (2023)

Rhizobium etli asparaginase II: An alternative for acute lymphoblastic leukemia (ALL) treatment
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2013)

Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia
por: Andrade, Augusto F, et al.
Publicado: (2014)

Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts
por: Métayer, Lucy E., et al.
Publicado: (2018)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
por: Sassen, Sebastiaan D.T., et al.
Publicado: (2017)

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
por: Juluri, Krishna R, et al.
Publicado: (2022)

Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
por: van der Sluis, Inge M., et al.
Publicado: (2022)

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
por: Ferguson, Daniel C., et al.
Publicado: (2022)

Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report
por: Tanaka, Ryuma, et al.
Publicado: (2012)

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia
por: Koprivnikar, Jamie, et al.
Publicado: (2017)

The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL)
por: Aisyi, Mururul, et al.
Publicado: (2019)

Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase
por: Jameel, Patel Zeeshan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fkfnsi2jbo9rp1mrgthupm81ft